Development and Validation of a Combined Ferroptosis and Immune Prognostic Classifier for Hepatocellular Carcinoma

Background Immunotherapy and sorafenib exert anti-tumor effects via ferroptosis, but reliable biomarkers for the individual treatment and prognosis prediction of hepatocellular carcinoma (HCC) based on the ferroptosis and immune status remain lacking. Methods Ferroptosis-related genes (FRGs) were id...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Yang Liu, Xi Zhang, Junjun Zhang, Juan Tan, Jie Li, Zewen Song
Aineistotyyppi: Artigo
Kieli:englanti
Julkaistu: 2020
Linkit:https://doi.org/10.3389/fcell.2020.596679
https://www.frontiersin.org/articles/10.3389/fcell.2020.596679/pdf
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!